Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of ($1.22), $0.01 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $8.71 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours